MOLKENTIN MICHAEL

CIK 00012689571 companyDUBLIN, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001268957

Recent Transactions

21 trades

Disposition to Issuer
Astex Pharmaceuticals, Inc
Employee Stock Option (Right to buy)
2013-10-11−160,000→ 0 total
Disposition to Issuer
Astex Pharmaceuticals, Inc
Employee Stock Option (Right to buy)
2013-10-11−96,000→ 0 total
Disposition to Issuer
Astex Pharmaceuticals, Inc
Employee Stock Option (Right to buy)
2013-10-11−150,000→ 0 total
Disposition to Issuer
Astex Pharmaceuticals, Inc
Employee Stock Option (Right to buy)
2013-10-11−42,750→ 0 total
Disposition to Issuer
Astex Pharmaceuticals, Inc
Employee Stock Option (Right to buy)
2013-10-11−110,000→ 0 total
Disposition from Tender
Astex Pharmaceuticals, Inc
Common Stock
2013-10-11−28,874→ 0 total
Disposition to Issuer
Astex Pharmaceuticals, Inc
Employee Stock Option (Right to buy)
2013-10-11−25,000→ 0 total
Disposition to Issuer
Astex Pharmaceuticals, Inc
Employee Stock Option (Right to buy)
2013-10-11−67,500→ 0 total
Disposition to Issuer
Astex Pharmaceuticals, Inc
Employee Stock Option (Right to buy)
2013-10-11−60,000→ 0 total
Exercise/Conversion
Astex Pharmaceuticals, Inc
Employee Stock Option (Right to buy)
2013-04-10−7,500→ 67,500 total
Exercise/Conversion
Astex Pharmaceuticals, Inc
Common Stock
2013-04-10$1.65/sh+7,500→ 26,495 total
Award
Astex Pharmaceuticals, Inc
Employee Stock Option (Right to buy)
2012-12-06+160,000→ 160,000 total
Award
Astex Pharmaceuticals, Inc
Employee Stock Option (Right to buy)
2012-03-07+160,000→ 160,000 total
Exercise/Conversion
Astex Pharmaceuticals, Inc
Common Stock
2011-05-19$1.65/sh+5,000→ 15,995 total
Exercise/Conversion
Astex Pharmaceuticals, Inc
Employee Stock Option (Right to buy)
2011-05-19−5,000→ 75,000 total
Award
Astex Pharmaceuticals, Inc
Employee Stock Option (Right to buy)
2011-03-24+150,000→ 150,000 total
Award
Astex Pharmaceuticals, Inc
Employee Stock Option (Right to buy)
2010-03-11+110,000→ 110,000 total
Award
Astex Pharmaceuticals, Inc
Employee Stock Option (Right to buy)
2009-03-12+80,000→ 80,000 total
Purchase
Astex Pharmaceuticals, Inc
Common Stock
2008-05-15$2.57/sh+250→ 5,352 total
Award
Astex Pharmaceuticals, Inc
Common Stock
2008-05-14$2.13/sh+1,351→ 5,102 total
Award
Astex Pharmaceuticals, Inc
Employee Stock Option (right to buy)
2003-11-04+100,000→ 100,000 total

Companies

Astex Pharmaceuticals, Inc
Chief Financial Officer

Recent Filings

Address

C/O SUPERGEN, INC. 4140 DUBLIN BOULEVARD, SUITE 200

DUBLIN, CA, 94568

View on SEC.gov